Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population

被引：0
|
作者：
Wendy Y. Cheng
Sujata P. Sarda
Nikita Mody-Patel
Sangeeta Krishnan
Mihran Yenikomshian
Malena Mahendran
Dominique Lejeune
Louise H. Yu
Mei Sheng Duh
机构：
[1] Analysis Group,
[2] Inc.,undefined
[3] Apellis Pharmaceuticals,undefined
[4] Inc.,undefined
[5] Groupe d’analyse,undefined
[6] Ltée,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Paroxysmal nocturnal hemoglobinuria; Eculizumab; Blood transfusion; Treatment patterns; Healthcare resource utilization; Medical costs; Absenteeism; Economic burden; Retrospective study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4461 / 4479
页数：18
相关论文
共 50 条
  • [1] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise H.
    Duh, Mei Sheng
    [J]. ADVANCES IN THERAPY, 2021, 38 (08) : 4461 - 4479
  • [2] Real-World Treatment Patterns and Healthcare Resource Utilization (HRU) of Patients (Pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Scoble, Patrick J.
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Duh, Mei Sheng
    [J]. BLOOD, 2020, 136
  • [3] PREVALENCE, REAL-WORLD HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE US: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
    Tantravahi, S.
    Latremouille-Viau, D.
    Desai, R.
    Lee, S.
    Paulose, J.
    Geevarghese, A.
    Guerin, A.
    Seshasayee, S.
    Tabatabaeepour, N.
    Chanpura, M.
    Yen, G.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S140 - S140
  • [4] Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Scoble, Patrick J.
    Kunzweiler, Colin
    Vu, Jensen Duy
    Cheung, Hoi Ching
    Duh, Mei Sheng
    [J]. BLOOD, 2020, 136
  • [5] Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Kunzweiler, Colin
    Vu, Jensen Duy
    Cheung, Hoi Ching
    Duh, Mei Sheng
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 357 - 369
  • [6] REAL-WORLD DOSING PATTERNS OF ECULIZUMAB-NAIVE AND ECULIZUMAB-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RECEIVING RAVULIZUMAB IN THE US
    Cheng, W. Y.
    Fishman, J.
    Yenikomshian, M.
    Mahendran, M.
    Kunzweiler, C.
    Vu, J. D.
    Duh, M. S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S493 - S493
  • [7] Healthcare resource utilization from OPERA: A real-world study of pegcetacoplan treatment in US adults with paroxysmal nocturnal hemoglobinuria
    Fishman, Jesse
    Min, Jinny
    Arnett, Lily
    Shenoy, Apeksha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 543 - 544
  • [8] Real-World Efficacy of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria in South Korea: Paradox of Eculizumab
    Kang, Ka-Won
    Moon, Hyemi
    Lee, Byung-Hyun
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    Lee, Juneyoung
    Park, Yong
    [J]. BLOOD, 2019, 134
  • [9] Real-World Ravulizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Fishman, Jesse
    Sarda, Sujata P.
    Krishnan, Sangeeta
    Kunzweiler, Colin
    Vu, Jensen Duy
    Yenikomshian, Mihran
    Duh, Mei Sheng
    [J]. BLOOD, 2021, 138
  • [10] HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INITIATING ECULIZUMAB AND RAVULIZUMAB: A US CLAIMS ANALYSIS
    Lin, C. W.
    Wang, R.
    Tzeng, E.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S117 - S117
12345